⚠ FOR RESEARCH USE ONLY
BPC-157

CHEMICAL PROPERTIES

CAS NUMBER137525-51-0
MOLECULAR WEIGHT1419.56 g/mol
MOLECULAR FORMULAC₆₂H₉₈N₁₆O₂₂

PHYSICAL PROPERTIES

APPEARANCEWhite lyophilized powder in sealed borosilicate glass vial.
SEQUENCEGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Tissue Repair Research

BPC-157

Body Protection Compound-157 is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Extensively studied in preclinical models for its regenerative and cytoprotective properties across multiple tissue types.

1
Free shipping on orders over $150
2-day delivery
LOT NUMBERLMO-0626-BPC-005
REPORT NO.RPT-20003
HPLC PURITY99.14%

7× Independently Tested

HPLC PurityIndependent lab
IdentitySequence confirmed
Net ContentExact mg verified
SterilityContamination-free
EndotoxinsLAL tested
Heavy MetalsICP-MS screened
Batch ConsistencyLot-to-lot stability
7×
TESTED
⚠

RESEARCH USE ONLY

This compound is sold strictly for in vitro research and laboratory use. Not for human or animal consumption. Not a drug, food, or supplement. By purchasing you confirm you are a qualified researcher and will use this compound in compliance with all applicable laws. Must be 21 or older.

RESEARCH

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Seiwerth S, Milavic M, Vukojevic J, et al. · Frontiers in Pharmacology · 2021
Reviews BPC-157 wound-healing activity across skin, fistula, burn and diabetic ulcer models, demonstrating equipotent efficacy across multiple routes of administration.
PMID 34276386
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
Liao H-J, Chen H-T, Chang C-H, et al. · Current Sports Medicine Reports · 2025
Documents BPC-157 mechanisms including VEGFR2 activation, Akt-eNOS nitric oxide synthesis, and ERK1/2 signalling that drive angiogenesis, fibroblast activity, and neuromuscular stabilisation in tendon and myotendinous junction models.
PMID 40789979
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, et al. · Sports Health · 2025
Systematic review of 36 studies (1993–2024) reporting improved healing outcomes in fracture, tendon rupture, ligament tear, and muscle injury models through growth factor upregulation and anti-inflammatory action.
PMID 40184576

LAB RESULTS

LOT LMO-0626-BPC-005 · CURRENT

Certificate of Analysis

PURITY
99.14%
CAS
137525-51-0
MW
1419.56 g/mol
APPEARANCE
White lyophilized powder in sealed borosilicate glass vial.
VERIFIED

Third-Party Report

TESTING LABIndependent Analytics LLC
TEST DATEJanuary 2025
METHODS USED
HPLCMSAAA
RESEARCH APPLICATIONS

What the literature covers.

  • ●Studied in tendon-to-bone healing and ligament regeneration models
  • ●Investigated for angiogenic effects via VEGF pathway modulation
  • ●Evaluated for cytoprotective effects in gastric mucosal research
  • ●NO-system interactions studied in preclinical cardiovascular models

All compounds sold by Lumo are intended strictly for in vitro research and laboratory use only. These products are NOT intended for human consumption, medical, veterinary, or household use. By purchasing from Lumo, you acknowledge that you are a qualified researcher or institution and will use these products solely for research purposes in compliance with all applicable laws and regulations.

L-003

Stay current.

New lot releases, research updates, and product announcements.

Unsubscribe anytime. Research use communications only.

Research Use Only · Not for Human Consumption · For Laboratory Research Purposes Only

Your Cart

● All items for research use only. Not for human consumption.
●

Your cart is empty

Add compounds to get started